Opportunity Information: Apply for CDC RFA JG 26 0054
Apply for CDC RFA JG 26 0054
- The Centers for Disease Control-GHC in the health sector is offering a public funding opportunity titled "Strengthening global health security through local partnerships in Uganda" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.318.
- This funding opportunity was created on 2026-07-14.
- Applicants must submit their applications by 2026-08-14. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 3 candidate(s).
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Unrestricted.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Strengthening global health security through local partnerships in Uganda" (Funding Opportunity Number CDC RFA JG 26 0054) is a CDC global health cooperative agreement focused on helping Uganda improve how quickly it can detect, report, and respond to public health threats. The overall aim is to strengthen national systems that prevent outbreaks from spreading and to make emergency responses more coordinated, better funded, and more effective across human health, animal health, and other relevant sectors.
The work is grounded in the gaps identified in Uganda's 2023 Joint External Evaluation (JEE), which is a standardized assessment of a country's health security capabilities. The notice highlights priority needs in core areas such as public health surveillance, laboratory systems, rapid response capacity, and the ability to deploy medical and other countermeasures for high-priority human and zoonotic diseases. It also emphasizes preparedness for water-related threats and broader multi-hazard, multi-sectoral readiness, aligned with Uganda's National Action Plan for Health Security. In practical terms, this points to investments that improve early warning, verification of suspected events, confirmation through testing, and quick field response, while strengthening coordination among ministries and partners that share responsibility for health security.
A major piece of the opportunity is improving the policy and financing environment for emergencies. The NOFO explicitly calls for support to national legislation and to the operationalization of functional, real-time funding mechanisms for health emergencies. That indicates a push beyond temporary, ad hoc outbreak funding toward a system where resources can be released quickly and predictably when an event occurs, helping reduce delays that often worsen outbreaks.
The opportunity also highlights border health as a national priority, including establishing a national border health program. This reflects the reality that cross-border movement can accelerate spread of infectious diseases, and that well-designed border health functions can improve screening, reporting, referral pathways, and coordination with neighboring countries. Stronger border systems also support compliance with international health obligations and strengthen readiness for threats that move along trade and travel routes.
Another central focus is data systems and real-time integration. The NOFO describes rolling out a functional electronic platform that expands the National Integrated Surveillance System (NISS). The intent is to link surveillance, laboratory information, case notification, emergency response operations, routine reporting, and workforce tracking data for priority human and zoonotic diseases. In effect, the CDC is signaling that Uganda should move toward a more unified, interoperable system where decision-makers can see the same picture across detection, confirmation, and response, and where workforce and response assets can be tracked to support deployment and accountability.
Administratively, this is a discretionary funding opportunity offered by the Centers for Disease Control and Prevention, specifically through CDC GHC (Global Health Center), and it will be funded as a cooperative agreement. A cooperative agreement generally means the CDC expects substantial involvement during implementation, such as technical collaboration, joint planning, and ongoing performance monitoring. The assistance listing (CFDA) number is 93.318, the application deadline is listed as 2026-08-14, and the expected number of awards is three. The posted award ceiling is shown as 0, which usually means the public listing does not specify a maximum award amount in that field and applicants need to consult the full announcement for budget expectations, limits, and funding ranges.
Eligibility is broadly defined and includes many types of domestic entities, such as state and local governments, tribal governments and organizations, public and private institutions of higher education, nonprofit organizations (with or without 501(c)(3) status), for-profit organizations (including small businesses), public housing authorities, and the listing notes "unrestricted." In practice, organizations applying would typically need to demonstrate strong technical capacity and credible partnerships to support national systems in Uganda, particularly in surveillance and laboratory strengthening, emergency preparedness and response, cross-sector coordination, and development or scale-up of integrated digital health security platforms.
FAQs: Strengthening global health security through local partnerships in Uganda (CDC RFA JG 26 0054)
What is the title of this grant opportunity?
The opportunity is titled "Strengthening global health security through local partnerships in Uganda".
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is CDC RFA JG 26 0054.
Which federal agency is offering this opportunity?
This is a discretionary funding opportunity offered by the Centers for Disease Control and Prevention (CDC), specifically through CDC GHC (Global Health Center).
What type of funding mechanism is being used?
The funding mechanism is a cooperative agreement.
What does it mean that this award is a cooperative agreement?
In a cooperative agreement, the CDC typically expects substantial involvement during implementation. Based on the notice description, that can include technical collaboration, joint planning, and ongoing performance monitoring as activities are carried out.
What is the overall purpose of this opportunity?
The purpose is to help Uganda detect, report, and respond to public health threats faster by strengthening national systems designed to prevent outbreaks from spreading and to make emergency responses more coordinated, better funded, and more effective across human health, animal health, and other relevant sectors.
What national assessment or framework is this work grounded in?
The work is grounded in the gaps identified in Uganda's 2023 Joint External Evaluation (JEE), a standardized assessment of a country's health security capabilities.
Which technical areas are highlighted as priority needs?
The notice emphasizes gaps and needs in core areas including public health surveillance, laboratory systems, rapid response capacity, and the ability to deploy medical and other countermeasures for high-priority human and zoonotic diseases.
Does the opportunity include zoonotic (human-animal) disease preparedness?
Yes. The description repeatedly references priority human and zoonotic diseases and calls for coordination across human health, animal health, and other relevant sectors.
Is preparedness for water-related threats included?
Yes. The opportunity specifically emphasizes preparedness for water-related threats as part of broader readiness efforts.
Is this intended to support a single hazard area or broader readiness?
The description points to multi-hazard, multi-sectoral readiness, rather than focusing on only one type of outbreak or threat.
How does this opportunity align with Uganda's national plans?
The work is described as aligned with Uganda's National Action Plan for Health Security.
What kinds of practical improvements are implied for detection and response?
Based on the notice, the opportunity points toward investments that strengthen early warning, verification of suspected events, confirmation through testing, and quick field response, alongside improved coordination among ministries and partners involved in health security.
What does the opportunity say about policy and financing for emergencies?
A major focus is improving the policy and financing environment for emergencies. The notice explicitly calls for support to national legislation and to the operationalization of functional, real-time funding mechanisms for health emergencies.
What is meant by "real-time funding mechanisms" for health emergencies?
From the description provided, this indicates a shift away from temporary or ad hoc outbreak funding toward a system where resources can be released quickly and predictably when an event occurs, reducing delays that can worsen outbreaks.
Is border health included as part of the grant priorities?
Yes. The opportunity highlights border health as a national priority, including the establishment of a national border health program.
Why does the notice emphasize border health?
The notice links border health to the reality that cross-border movement can accelerate the spread of infectious diseases. Strengthened border functions can improve screening, reporting, referral pathways, and coordination with neighboring countries, and can also support readiness for threats moving along trade and travel routes.
What does the opportunity say about data systems and integration?
Data systems and real-time integration are central. The notice describes rolling out a functional electronic platform that expands the National Integrated Surveillance System (NISS).
What is the intended scope of the electronic platform expanding NISS?
The intent is to link surveillance, laboratory information, case notification, emergency response operations, routine reporting, and workforce tracking data for priority human and zoonotic diseases.
What is the overall goal of integrating these data sources?
The notice signals movement toward a more unified, interoperable system where decision-makers can share a common operational picture across detection, confirmation, and response, and where workforce and response assets can be tracked to support deployment and accountability.
What is the Assistance Listing (CFDA) number for this opportunity?
The Assistance Listing (CFDA) number is 93.318.
What is the application deadline?
The application deadline listed is 2026-08-14.
How many awards does CDC expect to make?
The expected number of awards is three (3).
Is there a published maximum award amount (ceiling)?
The posted award ceiling is shown as 0. This typically means the public listing does not specify a maximum award amount in that field and that applicants need to consult the full announcement for budget expectations, limits, and funding ranges.
Who is eligible to apply?
Eligibility is described broadly and includes many types of domestic entities, including: state and local governments; tribal governments and organizations; public and private institutions of higher education; nonprofit organizations (with or without 501(c)(3) status); for-profit organizations (including small businesses); and public housing authorities. The listing notes "unrestricted".
Does eligibility include for-profit organizations and small businesses?
Yes. The eligibility description explicitly includes for-profit organizations, including small businesses.
Does eligibility require 501(c)(3) nonprofit status?
No. The eligibility description includes nonprofit organizations with or without 501(c)(3) status.
What kinds of capabilities should applicants be prepared to demonstrate?
Based on the notice summary, applicants would typically need to demonstrate strong technical capacity and credible partnerships to support national systems in Uganda, especially in surveillance and laboratory strengthening, emergency preparedness and response, cross-sector coordination, and the development or scale-up of integrated digital health security platforms.
Browse more opportunities from the same category: Health
Next opportunity: Spinal Cord Injury (SCI) Model Systems National Data and Statistical Center
Previous opportunity: Sustaining Global Health Security to protect and improve public health in Kenya
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA JG 26 0054
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA JG 26 0054) also looked into and applied for these:
| Funding Opportunity |
|---|
| Limited Competition: Instrumentation Grant Program for Resource-Limited Institutions (S10 - Clinical Trial Not Allowed) Apply for PAR 27 067 Funding Number: PAR 27 067 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trial Not Allowed) Apply for RFA DA 27 015 Funding Number: RFA DA 27 015 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers (U01 Clinical Trial Required) Apply for RFA DK 27 121 Funding Number: RFA DK 27 121 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Silvio O. Conte Digestive Diseases Research Core Centers (P30-Clinical Trial Optional) Apply for RFA DK 27 119 Funding Number: RFA DK 27 119 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| HeartShare 2.0: Refining Heart Failure Subtypes and Treatment Targets for Personalized Clinical Trials - Clinical Trial Center and Clinical Centers (U01 Clinical Trial Optional) Apply for RFA HL 27 008 Funding Number: RFA HL 27 008 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Single Source: HeartShare 2.0: Refining Heart Failure Subtypes and Treatment Targets for Personalized Clinical Trials - Data Translation Center (U54 Clinical Trial Optional) Apply for RFA HL 27 009 Funding Number: RFA HL 27 009 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Biomedical Technology Optimization and Dissemination Center (BTOD) (RM1 - Clinical Trial Not Allowed) Apply for PAR 27 024 Funding Number: PAR 27 024 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Research Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA DK 27 136 Funding Number: RFA DK 27 136 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| ACL National Resource Center on Nutrition and Aging Apply for HHS 2026 ACL AOA PPNU 0003 Funding Number: HHS 2026 ACL AOA PPNU 0003 Agency: Administration for Community Living Category: Health Funding Amount: $1,014,596 |
| A Demonstration to Scale Innovative Person-Centered Approaches to Falls Prevention through Clinical-Community Partnerships Apply for HHS 2026 ACL CIP AAFP 0017 Funding Number: HHS 2026 ACL CIP AAFP 0017 Agency: Administration for Community Living Category: Health Funding Amount: $4,700,000 |
| Scaling Evidence-Based Falls Prevention Programs Apply for HHS 2026 ACL AOA FPSG 0004 Funding Number: HHS 2026 ACL AOA FPSG 0004 Agency: Administration for Community Living Category: Health Funding Amount: $740,162 |
| ACL National Falls Prevention Resource Center Apply for HHS 2026 ACL AOA FPSG 0005 Funding Number: HHS 2026 ACL AOA FPSG 0005 Agency: Administration for Community Living Category: Health Funding Amount: $2,500,000 |
| Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed) Apply for PAR 27 022 Funding Number: PAR 27 022 Agency: National Institutes of Health Category: Health Funding Amount: $5,000,000 |
| Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) Apply for RFA CA 27 002 Funding Number: RFA CA 27 002 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) Apply for RFA CA 27 001 Funding Number: RFA CA 27 001 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
| Kidney Precision Medicine Project Recruitment Sites (U01 Clinical Trial Not Allowed) Apply for RFA DK 27 301 Funding Number: RFA DK 27 301 Agency: National Institutes of Health Category: Health Funding Amount: $450,000 |
| Kidney Precision Medicine Project Tissue Interrogation Sites (U01 Clinical Trial Not Allowed) Apply for RFA DK 27 302 Funding Number: RFA DK 27 302 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| Nutrition Obesity Research Centers (NORCs) (P30 Clinical Trial Optional) Apply for RFA DK 27 120 Funding Number: RFA DK 27 120 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Single Source: Post-Stroke Vascular Contributions to Cognitive Impairment and Dementia (VCID) in the United States (U19 - Clinical Trial Not Allowed) Apply for RFA NS 27 011 Funding Number: RFA NS 27 011 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Science Track Award for Research Transition (START) Program (R03, Clinical Trial Optional) Apply for PAS 27 028 Funding Number: PAS 27 028 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA JG 26 0054", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.